Arcturus Therapeutics Holdings Inc. Gains 24.02%
Wed 11 Nov 20 at 05:30 PM
Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ) soared at $48.84, representing a gain of 24%. The stock appeared on our News Catalysts scanner on Wed 11 Nov 20 at 08:46 AM in the 'EARNINGS' category. From Tue 27 Oct 20, the stock recorded 70.00% Up Days and 72.73% Green Days
The stock spiked on Fri 21 Aug 20 at $66.24 with a volume of 1M+.
About Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ)
Arcturus Therapeutics Ltd is a biotechnology company developing novel RNA medicines. The company develops novel RNA medicines in therapeutic areas including infectious disease, cystic fibrosis, nonalcoholic steatohepatitis (NASH) and rare liver diseases.
Top 10 Gainers:
- Five Prime Therapeutics, Inc. (FPRX:NASDAQ), 237.08%
- Fuel Tech, Inc. (FTEK:NASDAQ), 64.26%
- Equillium, Inc. (EQ:NASDAQ), 44.83%
- GRAY (GRAY:NASDAQ), 35.27%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 34.66%
- Genfit SA (GNFT:NASDAQ), 28.79%
- Immuron Limited (IMRN:NASDAQ), 24.44%
- Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ), 24.02%
- Revlon, Inc. (REV:NYSE), 22.53%
- Celcuity Inc. (CELC:NASDAQ), 22.03%